Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Non-Current Deffered Revenue (2023 - 2025)

Historic Non-Current Deffered Revenue for SANUWAVE Health (SNWV) over the last 3 years, with Q3 2025 value amounting to $322000.0.

  • SANUWAVE Health's Non-Current Deffered Revenue fell 1005.59% to $322000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $322000.0, marking a year-over-year decrease of 1005.59%. This contributed to the annual value of $300000.0 for FY2024, which is 1354.47% down from last year.
  • According to the latest figures from Q3 2025, SANUWAVE Health's Non-Current Deffered Revenue is $322000.0, which was down 1005.59% from $301000.0 recorded in Q2 2025.
  • SANUWAVE Health's Non-Current Deffered Revenue's 5-year high stood at $358000.0 during Q3 2024, with a 5-year trough of $215000.0 in Q2 2023.
  • For the 3-year period, SANUWAVE Health's Non-Current Deffered Revenue averaged around $304818.2, with its median value being $311000.0 (2025).
  • In the last 5 years, SANUWAVE Health's Non-Current Deffered Revenue soared by 6279.07% in 2024 and then tumbled by 1400.0% in 2025.
  • SANUWAVE Health's Non-Current Deffered Revenue (Quarter) stood at $347000.0 in 2023, then dropped by 13.54% to $300000.0 in 2024, then increased by 7.33% to $322000.0 in 2025.
  • Its Non-Current Deffered Revenue was $322000.0 in Q3 2025, compared to $301000.0 in Q2 2025 and $311000.0 in Q1 2025.